Endocrinology

Host: Steven Edelman, MD

Guest: R. Keith Campbell, BPharm, MBA

Changes in both care and treatment of diabetes reflect trends in healthcare that may need revision. How can healthcare professionals benefit from new pharmacotherapies for their patients living with diabetes? Join host Dr. Steven Edelman and his guest, professor of pharmacy, Keith Campbell, as they discuss trends in healthcare that may require revisions for the care of people living with diabetes.

Host: Janice Baker, MBA, RD, CDE, CNSC

Guest: Sally Hara, MS, RD, CDE, CSSD

Exercise is essential for controlling blood sugar levels in patients with diabetes but benefits also present a set of unique challenges to athletes. What are the concerns medical professionals should be aware of and monitor for their athletes living with diabetes? Join guest host Janice Baker and Sally Hara, certified specialist in sports dietetics, as they discuss prescribing exercise regimens for the diabetic athletes.

Host: Janice Baker, MBA, RD, CDE, CNSC

Guest: Monika Woolsey

There are many challenges in overall diabetes management relative to a patients' mindful integration of food and behavior. What do healthcare professionals need to know to help their patients with diabetes better manage diet, stress and physical activity? Join guest host Janice Baker, CDE, RD and her guest, president and founder of "After The Diet" network, Monika Woolsey, RD, as they discuss the biochemistry and appetite regulation of diabetes and diet.

Host: Janice Baker, MBA, RD, CDE, CNSC

Guest: William Polonsky, PhD, CDE

Stress is an integral element in the management of diabetes. What are key questions healthcare professionals can ask of their patients dealing with diabetes-related stress? Join guest host Janice Baker, CDE, RD and her guest, founder of the Behavioral Diabetes Institute, Dr. William Polonsky, as they discuss the basics of stress and diabetes and we can better help our patients living with diabetes.

Host: Steven Edelman, MD

Guest: John Buse, MD, PhD

The recent American Diabetes Association / European Association for the Study of Diabetes consensus panel produced their treatment algorithm to control glycaemia in type 2 diabetes. How can healthcare professionals treating patients with type 2 diabetes provide additional prandial intervention to reach A1c targets? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of North Carolina School of Medicine, Dr. John Buse, as they discuss the results of the glargine-exenatide combination study and its implications for a preferred treatment algorithm.

Host: Steven Edelman, MD

Guest: Jay Skyler, MD

Can immune intervention stop the disease process of type 1 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine, pediatrics and psychology at the University of Miami, Dr. Jay Skyler, as they discuss the diagnosis, screening, testing and current immunotherapy research for the prevention and intervention of type 1 diabetes.

Host: Mimi Secor, DNP, FNP-BC, FAANP

Guest: Christine Kessler

What makes Americans fat? Diet isn't entirely to blame. Christine Kessler, who is a nurse practitioner in the department of endocrinology and metabolic medicine at a Washington, DC, teaching hospital, joins host Mimi Secor to discuss the many variables that are attributed to obesity in this country. They also look at what nurse practitioners can do to help their patients come up with strategies for living healthier lives.

Host: Steven Edelman, MD

Guest: Craig Wargon, DPM

Patients with diabetes commonly need treatment for peripheral neuropathy. What are common symptoms and what should a physician be looking for in each patient visit? Join host Dr. Steven Edelman and his guest, practicing physician in the division of podiatric surgery at Kaiser Permanente, Dr. Craig Wargon, as they discuss symptoms, treatment and the need to glycaemic control in patients with diabetes.

Host: Maurice Pickard, MD

Guest: Gerald Reaven, MD

Metabolic syndrome is generally considered to be a combination of conditions that increases a patient's risk of developing coronary artery disease. These conditions include elevated blood pressure, obesity, insulin resistance, elevated C-reactive proteins and high triglycerides or HDL cholesterol. If a patient has three or more of these conditions, he or she is classified as having metabolic syndrome. But what is the clinical applicability of this "syndrome," and should practicing physicians still be using the metabolic syndrome concept? Dr. Gerald Reaven, active emeritus professor of medicine at the Stanford University School of Medicine in Stanford, California, suggests that there are more reliable methods than the metabolic syndrome classification for determining a patient's risk of developing coronary artery disease. Dr. Maurice Pickard hosts.

Host: Steven Edelman, MD

Guest: Ann Albright, PhD, RD

The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.